AB008. Utility of repeat latent tuberculosis testing in patients with immune-mediated diseases taking biologics

BACKGROUND: Guidelines for repeat latent tuberculosis infection (LTBI) testing while on biologics are not clearly defined. The CDC and U.S. Preventive Services Task Force recommend routine serial LTBI screening in high-risk patients, such as those on immunosuppressive medications. Furthermore, recom...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanna, Urmi, Ellis, Ariana, Gallop, Josh, Galadari, Abdulaziz, Hu, Jeffery, Fernandez, Anthony P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Abstract on Rheumatologic Skin Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033305/
http://dx.doi.org/10.21037/atm.2021.AB008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033305/
http://dx.doi.org/10.21037/atm.2021.AB008

Ejemplares similares